No CrossRef data available.
Article contents
Pharmacokinetic-based total intravenous anaesthesia using remifentanil and propofol for surgical myocardial revascularization
Published online by Cambridge University Press: 30 June 2005
Extract
Summary
Background and objective: We investigated the following aspects of pharmacokinetic-guided total intravenous anaesthesia with remifentanil and propofol in patients undergoing surgical myocardial revascularization: anaesthetic efficacy, haemodynamic effects, impact on extubation of the trachea and analgesia after operation.
Methods: Thirty-two patients undergoing on-pump coronary bypass surgery received intravenous anaesthesia with remifentanil and propofol. Both drugs were dosed and titrated based on computer-assisted pharmacokinetic models to maintain constant plasma concentrations. The propofol target plasma concentration was 1.2 μg mL−1 throughout the procedure. A remifentanil target plasma concentration of 8 ng mL−1 was achieved over 2 min for induction. After tracheal intubation, the opioid plasma concentration was reduced to 4 ng mL−1, and then titrated up to 8 ng mL−1 during surgery. Postoperative analgesia was managed with remifentanil infusion until 4 h after tracheal extubation, and a continuous infusion of tramadol was started 1 h before the remifentanil was stopped.
Results: After induction of anaesthesia, heart rate (−20%) and cardiac index (−6%) decreased significantly. No hypotensive episodes (mean arterial pressure <60 mmHg) occurred. Intraoperative haemodynamics were stable. Three cases of myocardial ischaemia were detected: two by transoesophageal echocardiography and one with ST-segment monitoring. The duration of postoperative mechanical ventilation of the lungs was 95 ± 13 min and the time to extubation was 150 ± 18 min. Postoperative analgesia was satisfactory in all patients.
Conclusions: Pharmacokinetic-based total intravenous anaesthesia with remifentanil and propofol provides adequate anaesthesia during coronary surgery with cardiopulmonary bypass and allows safe early extubation after operation.
Keywords
- Type
- Original Article
- Information
- Copyright
- 2003 European Society of Anaesthesiology
References
Lunn JK, Stanley TH, Eisele J, Webster L, Woodward A. High-dose fentanyl anesthesia for coronary artery surgery. Anesth Analg 1979; 58: 390–395.Google Scholar
Sebel PS, Bovill JG, Boekhorst RAA, Rog N. Cardiovascular effects of high-dose fentanyl anaesthesia. Acta Anaesthesiol Scand 1982; 26: 308–315.Google Scholar
Wynands JE, Townsend GE, Wong P, Whalley DG, Srikant CB, Patel YC. Blood pressure response and plasma fentanyl concentrations during high- and very high-dose fentanyl anesthesia for coronary artery surgery. Anesth Analg 1983; 62: 661–665.Google Scholar
Hilgenberg JC. Intraoperative awareness during high-dose fentanyl–oxygen anesthesia. Anesthesiology 1981; 54: 341–343.Google Scholar
Caspi J, Klausner JM, Safadi T, Amar R, Rozin RR, Merin G. Delayed respiratory depression following fentanyl anesthesia for cardiac surgery. Crit Care Med 1988; 16: 238–240.Google Scholar
De Lange S, Stanley TH, Boscoe MJ. Alfentanil–oxygen anaesthesia for coronary artery surgery. Br J Anaesth 1981; 53: 1291–1296.Google Scholar
Phillips AS, McMurray TJ, Mirakhur RK, Gibson FM, Elliott P. Propofol–fentanyl anaesthesia in cardiac surgery: a comparison in patients with good and impaired left ventricular function. Anaesthesia 1993; 48: 661–663.Google Scholar
Bell J, Sartain J, Wilkinson GA, Sherry KM. Propofol and fentanyl anaesthesia for patients with low cardiac output state undergoing cardiac surgery: comparison with high-dose fentanyl anaesthesia. Br J Anaesth 1994; 73: 162–166.Google Scholar
Roekaerts PM, Gerrits HJ, Timmerman BE, de Lange S. Continuous infusions of alfentanil and propofol for coronary artery surgery. J Cardiothorac Vasc Anesth 1995; 9: 362–367.Google Scholar
D'Attelis N, Nicolas-Robin A, Delayance S, Carpentier A, Baron JF. Early extubation after mitral valve surgery: a target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vasc Anesth 1997; 11: 467–473.Google Scholar
Olivier P, Sirieix D, Dassier P, D'Attellis N, Baron JF. Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery: a new approach for scheduled early extubation. J Cardiothorac Vasc Anesth 2000; 14: 29–35.Google Scholar
Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth 1997; 9: 23S–26S.Google Scholar
Shafer SL, Gregg KM. Algorithm to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm 1992; 20: 147–169.Google Scholar
Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10–23.Google Scholar
Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24–33.Google Scholar
Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41–48.Google Scholar
Glen JB. The development of ‘Diprifusor’: a TCI system for propofol. Anaesthesia 1998; 53 (Suppl 1): 13–21.Google Scholar
Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998; 53 (Suppl 1): 4–12.Google Scholar
Bigatello LM, Coppo A. Intraoperative monitoring of myocardial ischemia. Minerva Anestesiol 2001; 67: 314–319.Google Scholar